Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone [NA]

View source ↗

Summary

A clinical trial assessing a prophylactic regimen of intravenous oxytocin, intravenous tranexamic acid, and intramuscular methylergometrine for primary preventi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • Methylergometrine (methylergometrine)
  • Oxytocin (Oxytocin)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Cairo University | Conditions: Post Partum Hemorrhage | NA | Status: NOT_YET_RECRUITING